NCT00086307View on ClinicalTrials.gov

Lexapro and Pramipexole and to Treat Major Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Major Depression
Interventions
DRUG

Pramipexole

Pramipexole will be titrated so patients receive the following medication three times per day during the weeks noted: .125 milligrams (mg) in week 1, .250 mg in week 2, .5 mg in week 3, and .75 mg in weeks 4 to 6.

DRUG

Escitalopram

Escitalopram will be started at 10 mg/day and patients will continue on this throughout the study.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00086307 - Lexapro and Pramipexole and to Treat Major Depression | Biotech Hunter | Biotech Hunter